How to Get Fosamax (Alendronate) in West Virginia

What Alendronate (Fosamax) Actually Does

Alendronate is an oral bisphosphonate that inhibits osteoclast-mediated bone resorption, slowing the rate at which the body breaks down bone mineral. The result is a measurable increase in bone mineral density (BMD) and a reduction in fracture risk at the spine, hip, and wrist. The FDA approved alendronate for postmenopausal osteoporosis prevention and treatment in 1995, and the branded version Fosamax remains one of the most prescribed osteoporosis drugs in the United States. [1]

The Fracture Intervention Trial (FIT, N=2,027), published in JAMA in 1998, remains the cornerstone efficacy study. Women with low femoral-neck BMD who received alendronate 5 to 10 mg daily for 36 months showed a 51% relative risk reduction in hip fracture compared with placebo (P<0.001). [2] Vertebral fractures were reduced by 47% over the same period. Those numbers are not typical for a generic drug that costs less than $20 per month.

The standard adult dose for treatment of postmenopausal osteoporosis is alendronate 70 mg taken orally once per week, on the same day each week, first thing in the morning, with 8 oz of plain water, at least 30 minutes before any food, drink, or other medication. The 10 mg daily formulation is FDA-approved as well but has largely been replaced by the weekly formulation in clinical practice because of equivalent efficacy and better adherence. [1]

According to the 2020 American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) clinical practice guidelines: "Bisphosphonates, including alendronate, risedronate, zoledronic acid, and ibandronate, are recommended as first-line therapy for most patients with postmenopausal osteoporosis." [3]

West Virginia has a disproportionately high burden of osteoporosis-related fractures. CDC data indicate that West Virginia adults report some of the highest rates of arthritis and musculoskeletal conditions in the country, and hip fracture hospitalization rates in WV exceed the national average. [4] Getting a prescription started promptly matters.

Who Can Prescribe Fosamax in West Virginia

Any licensed prescriber in West Virginia with an active DEA registration and state medical license may prescribe alendronate. Alendronate is not a controlled substance, so the DEA registration requirement applies only in the sense that the prescriber must hold an active, unrestricted WV license.

Specifically, the following categories of clinicians can legally write a Fosamax prescription in West Virginia:

Medical Doctors (MDs) and Doctors of Osteopathic Medicine (DOs) licensed by the West Virginia Board of Medicine or the West Virginia Board of Osteopathic Medicine may prescribe without restriction.

Nurse Practitioners (NPs) in West Virginia operate under full practice authority as of 2016. An NP with an active Advanced Practice Registered Nurse (APRN) license and a DEA number may prescribe alendronate independently, without a supervising physician agreement.

Physician Assistants (PAs) may prescribe in West Virginia under a written supervisory agreement with a licensed physician. The prescribing PA must have an active PA license from the WV Board of Medicine and a collaborating physician on record.

Endocrinologists, rheumatologists, and OB-GYNs are the most common specialists who manage osteoporosis long-term. For routine cases, a primary care physician or telehealth provider is entirely appropriate.

The West Virginia Board of Medicine has explicitly stated that telehealth encounters that meet the standard of care, including a proper patient history and review of diagnostic data, constitute a valid patient-provider relationship sufficient to support prescribing. [5]

Telehealth Options for Getting Fosamax in West Virginia

West Virginia allows telehealth prescribing. You do not need to visit a physical clinic to start alendronate if you already have relevant diagnostic data, specifically a recent DEXA scan result and basic labs.

The West Virginia Legislature passed SB 437 in 2021, codifying that providers may establish a patient-physician relationship via synchronous audio-visual telehealth and may issue a prescription based on that encounter alone, provided the standard of care is met. [5] Alendronate, as a non-controlled medication, has no additional telehealth prescribing barriers beyond the standard requirements.

The typical telehealth pathway in WV looks like this:

1. Schedule a synchronous (video) visit with a WV-licensed telehealth provider, including platforms that serve WV such as HealthRX, Teladoc Health, MDLive, or an in-state endocrinology or primary care telehealth service.
2. Upload or share your most recent DEXA scan report (T-score at lumbar spine and femoral neck), serum calcium, 25-hydroxyvitamin D, creatinine, and CBC.
3. The clinician reviews your history, confirms the indication, checks for contraindications (specifically esophageal disorders or creatinine clearance <35 mL/min), and discusses risks.
4. The electronic prescription is sent directly to your preferred West Virginia pharmacy or a mail-order pharmacy licensed to ship to WV.
5. Most patients report receiving their first bottle within 3 to 7 business days of the initial visit.

If you do not have a current DEXA scan, the provider will order one. Imaging centers in Charleston, Huntington, Morgantown, and Parkersburg all offer DEXA services, typically at a cost of $75 to $150 out of pocket if insurance does not cover it. Once the DEXA result is returned, the telehealth follow-up to issue the prescription can often occur within 48 hours.

Required Labs and Diagnostics Before Starting Alendronate

A prescriber must confirm the diagnosis and rule out contraindications before writing the first prescription. Skipping this step is not clinically acceptable and any telehealth provider who does not request this information is not practicing to the standard of care.

The minimum pre-treatment workup recommended by AACE/ACE and the National Osteoporosis Foundation (NOF) includes the following:

DEXA scan with T-scores at the lumbar spine (L1-L4) and femoral neck. A T-score of -2.5 or lower meets the WHO diagnostic criteria for osteoporosis. A T-score between -1.0 and -2.5 is osteopenia, and treatment may still be indicated depending on the patient's FRAX 10-year fracture probability score.

Serum calcium to exclude hypocalcemia, which is an absolute contraindication to bisphosphonate therapy. Alendronate can worsen hypocalcemia and may cause severe symptomatic hypocalcemia if started without correction. [1]

25-hydroxyvitamin D (25-OH-D). Levels below 20 ng/mL indicate deficiency. AACE guidelines recommend correcting vitamin D to at least 30 ng/mL before and during bisphosphonate therapy. [3]

Serum creatinine and estimated GFR. Alendronate is contraindicated in patients with creatinine clearance <35 mL/min because the drug accumulates in bone and renal tissue at low GFR levels. [1]

CBC (complete blood count) to screen for hematologic conditions that might suggest secondary causes of bone loss, such as multiple myeloma.

TSH if the patient has any thyroid history, since uncontrolled hyperthyroidism is a reversible cause of bone loss.

Secondary osteoporosis workup (PTH, 24-hour urine calcium, SPEP) may be ordered at the provider's discretion, particularly in men or premenopausal women with low bone density.

A standard blood draw at any LabCorp, Quest Diagnostics, or WV hospital outpatient lab covers all of these markers. Many WV primary care clinics can run an in-house basic metabolic panel within the same-day visit. Results are typically available within 24 to 48 hours.

How Much Does Alendronate Cost in West Virginia Without Insurance

Generic alendronate 70 mg (4 tablets, one-month supply taken weekly) costs approximately $10 to $20 at most West Virginia retail pharmacies when purchased with a GoodRx, RxSaver, or similar discount coupon. Branded Fosamax is substantially more expensive, often $200 or more per month, and there is no clinical reason to choose the brand-name product over a generic since bioequivalence has been established by the FDA. [1]

GoodRx prices as of early 2025 show alendronate 70 mg (4 tablets) available at:

• CVS Pharmacy (Charleston, WV): approximately $14 with GoodRx coupon
• Kroger Pharmacy (Morgantown, WV): approximately $11 with coupon
• Walmart Pharmacy (Huntington, WV): approximately $9 on the $4/$10 generics list

These prices fluctuate by location and date. Always check the coupon price at your specific pharmacy before filling.

West Virginia Medicaid does not currently cover alendronate on its preferred drug list. [6] Patients on WV Medicaid may need to request a prior authorization (PA) or explore alternative agents. The WV Medicaid pharmacy program does cover risedronate and zoledronic acid under certain prior authorization criteria, which provides a path for patients who cannot afford out-of-pocket costs for alendronate.

Private insurance coverage varies. Most commercial plans in West Virginia, including those offered through the WV PEIA (Public Employees Insurance Agency), cover generic alendronate at Tier 1 or Tier 2, meaning a $5 to $30 copay per month.

Prior Authorization Requirements in West Virginia

Most commercial insurers in WV do not require prior authorization for generic alendronate 70 mg because it is a low-cost Tier 1 generic. Prior authorization is more commonly required when:

• The prescriber requests branded Fosamax instead of generic alendronate
• The insurer requires step therapy, meaning alendronate must be tried before a more expensive agent like denosumab (Prolia) or teriparatide (Forteo) is approved
• WV Medicaid is the payer (see above)

If PA is required, the prescriber typically needs to submit the following documentation:

1. DEXA scan result showing a T-score of -2.5 or lower, or a T-score of -1.0 to -2.5 with a FRAX 10-year major osteoporotic fracture probability of 20% or higher (per NOF thresholds)
2. Documentation that hypocalcemia and severe renal impairment have been excluded
3. Confirmation of a prior fragility fracture, if applicable, which generally accelerates PA approval
4. Prescriber's clinical notes confirming the diagnosis of osteoporosis or high-fracture-risk osteopenia

The PA process through most WV commercial insurers takes 3 to 5 business days. Urgent PA requests, for example after a hip fracture, can sometimes be resolved within 24 hours with a peer-to-peer review between the prescribing physician and the insurer's medical director.

Transferring an Existing Fosamax Prescription to West Virginia

If you move to West Virginia or temporarily relocate, your existing alendronate prescription can be transferred to a WV pharmacy under standard pharmacy transfer rules. A pharmacist at your new WV pharmacy contacts the original dispensing pharmacy to verify remaining refills and transfers the prescription electronically or by phone.

Alendronate is not a controlled substance, so there are no Schedule II-V transfer restrictions that would complicate the process. Most chain pharmacies (Walgreens, CVS, Kroger, Walmart) can complete a transfer within a few hours.

One practical note: if your original prescription was written by an out-of-state provider who is not licensed in West Virginia, the WV pharmacy cannot refill it once the original supply is exhausted. At that point, you need a new prescription from a WV-licensed provider. A telehealth visit to establish care and receive a new WV prescription takes as little as 15 to 30 minutes if your labs and DEXA data are current.

503A Compounding Pharmacies and Alendronate in West Virginia

West Virginia has licensed 503A compounding pharmacies that are legally permitted to compound alendronate preparations for individual patients under a valid prescription. The FDA classifies 503A pharmacies as traditional compounding pharmacies that operate under state pharmacy board oversight. [7]

However, compounded alendronate is almost never clinically necessary. The commercially manufactured generic tablet at $10 to $20 per month is already inexpensive, widely available, and FDA-approved for bioequivalence. A compounded formulation might be considered in rare cases where a patient has a documented allergy to an inactive ingredient in the commercial tablet (such as lactose or microcrystalline cellulose), or where a liquid formulation is needed for a patient with dysphagia who cannot safely swallow tablets.

If compounded alendronate is ordered in WV, the prescribing provider must document a clinical rationale. The WV Board of Pharmacy requires that 503A compounding pharmacies comply with USP 795 standards for non-sterile preparations. [8] Shipping of compounded alendronate within WV state lines is permitted; interstate shipping is subject to additional federal regulations.

Managing Alendronate Long-Term in West Virginia

Starting alendronate is straightforward. Staying on it correctly, and knowing when to stop, requires ongoing clinical oversight.

Adherence monitoring. Studies show that only about 50% of patients remain on oral bisphosphonate therapy at 12 months. [9] The once-weekly 70 mg schedule exists specifically because it improves adherence compared to daily dosing without sacrificing efficacy, as shown in the FOSIT study (N=1,258). [10] Setting a phone alarm on the same day each week reduces missed doses substantially.

Drug holiday considerations. After 3 to 5 years of alendronate therapy, AACE guidelines recommend a formal reassessment. Patients at moderate fracture risk may take a drug holiday of 1 to 2 years while retaining residual BMD benefit. Patients at high or very high fracture risk should generally continue therapy or transition to another agent. [3]

Esophageal safety. The most common serious adverse effect of oral alendronate is esophageal irritation or, rarely, esophageal ulceration. The 30-minute upright positioning requirement after each dose is not optional. Patients with Barrett's esophagus, active esophagitis, or significant GERD should discuss the risk-benefit profile carefully with their provider; intravenous zoledronic acid (Reclast, once yearly) is an alternative that avoids esophageal exposure entirely.

Atypical femoral fractures and osteonecrosis of the jaw. Both are rare. The absolute risk of atypical femoral fracture with alendronate use beyond 5 years is approximately 3.2 to 50 per 100,000 person-years, far lower than the fracture risk of untreated osteoporosis. [11] Osteonecrosis of the jaw risk is highest in oncology patients receiving high-dose IV bisphosphonates, not in patients on standard-dose oral alendronate for osteoporosis.

Calcium and vitamin D co-supplementation. AACE recommends 1,000 to 1 to 200 mg of elemental calcium per day (diet plus supplement combined) and 800 to 1 to 000 IU of vitamin D3 daily for all patients on bisphosphonate therapy. [3] Neither supplement should be taken within 30 minutes of the alendronate dose because divalent cations impair bisphosphonate absorption.

Follow-up DEXA. Repeat DEXA scanning 1 to 2 years after initiating alendronate confirms BMD response. A BMD increase of 3% to 6% at the lumbar spine is a typical response at 12 to 24 months. Failure to respond or continued BMD decline may indicate secondary osteoporosis, poor adherence, or malabsorption of the drug.

West Virginia residents using telehealth for ongoing management should confirm that their telehealth provider offers follow-up appointments and can order repeat labs and imaging through WV-based facilities. A single visit to start the prescription is not a complete osteoporosis management program.